Cargando…
How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer
Background: The role of real-world evidence (RWE) in the development of anticancer therapies has been gradually growing over time. Regulators, payers and health technology assessment agencies, spurred by the rise of the precision medicine model, are increasingly incorporating RWE into their decision...
Autores principales: | Saesen, Robbe, Kantidakis, Georgios, Marinus, Ann, Lacombe, Denis, Huys, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449152/ https://www.ncbi.nlm.nih.gov/pubmed/36091761 http://dx.doi.org/10.3389/fphar.2022.969778 |
Ejemplares similares
-
Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
por: Broes, Stefanie, et al.
Publicado: (2020) -
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
por: Saesen, Robbe, et al.
Publicado: (2020) -
Real-world data in oncology: a questionnaire-based analysis of the academic research landscape examining the policies and experiences of the cancer cooperative groups
por: Saesen, R., et al.
Publicado: (2023) -
Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments
por: Saesen, Robbe, et al.
Publicado: (2023) -
Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders
por: Dooms, M, et al.
Publicado: (2022)